Observational studyAnnals of neurology2025

Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort Study.

Paolo Antonio Muraro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.